Drugs / CT1194D
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07200479 | Oct 2025 → Jun 2027 expected | B-cell neoplasm | Institute of Hematology & Blood Diseases Hospital, China | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CT1194D | “CT1194D CAR-T Cells” NCT07200479 ↗ |
| Modality | Cell therapy | “CT1194D CAR-T Cells” NCT07200479 ↗ |